Below is a quote from PDR: "No adequate and well-controlled studies have been conducted to evaluate the use of olopatadine (Pataday) during human pregnancy; however, published data from postmarketing use of antihistamines with similar mechanisms of action to olopatadine have not identified a drug-associated risk for major birth defects, miscarriages, or adverse maternal or fetal outcomes"
Answered 5/6/2021
0 views
A doctor has provided 1 answer
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question